Summit Trail Advisors LLC raised its position in shares of Gilead Sciences, Inc. ( NASDAQ:GILD – Free Report ) by 50.7% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 8,915 shares of the biopharmaceutical company's stock after acquiring an additional 3,000 shares during the quarter. Summit Trail Advisors LLC's holdings in Gilead Sciences were worth $740,000 at the end of the most recent quarter. Several other large investors have also bought and sold shares of GILD.

https://www.dailypolitical.com/2023/07/31/summit-trail-advisors-llc-purchases-3000-shares-of-gilead-sciences-inc-nasdaqgild.html

#dailypolitical